ICECURE MEDICAL LTD (ICCM) Stock Price, Quote, News and Overview
NASDAQ:ICCM - Nasdaq - IL0011224156 - Common Stock - Currency: USD
ICCM Quote, Performance and Key Statistics
NASDAQ:ICCM (2/21/2025, 8:27:27 PM)
1.41
-0.09 (-6%)
The current stock price of ICCM is 1.41 USD. In the past month the price increased by 13.71%. In the past year, price increased by 6.82%.
ICCM Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 28.89 | 234.01B | ||
| ISRG | INTUITIVE SURGICAL INC | 80.74 | 211.07B | ||
| BSX | BOSTON SCIENTIFIC CORP | 41.63 | 154.00B | ||
| SYK | STRYKER CORP | 31.4 | 145.92B | ||
| MDT | MEDTRONIC PLC | 16.84 | 115.33B | ||
| BDX | BECTON DICKINSON AND CO | 16.35 | 65.30B | ||
| EW | EDWARDS LIFESCIENCES CORP | 27.98 | 43.23B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 20.29 | 41.62B | ||
| IDXX | IDEXX LABORATORIES INC | 40.25 | 37.07B | ||
| DXCM | DEXCOM INC | 53.81 | 34.68B | ||
| RMD | RESMED INC | 26.21 | 34.03B | ||
| PHG | KONINKLIJKE PHILIPS NVR- NY | 17.5 | 24.02B |
Related stock screener links
About ICCM
Company Profile
IceCure Medical Ltd. is a commercial stage medical device company. The firm operates as commercial stage medical device company focusing on the research, development and marketing of cryoablation systems, disposables and technologies based on liquid nitrogen, or LN2, for treating tumors. Cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in breast, lungs, kidneys, bones and other indications. Company's lead product is ProSense system, a single probe system, but in addition the Company developed an additional multi probe system that is expected to have the ability to freeze several tumors simultaneously or larger tumors, named MultiSense system, which has not yet been commercialized.
Company Info
ICECURE MEDICAL LTD
7 Ha'eshel St., PO Box 3163
CAESAREA IL
CEO: EYAL SHAMIR
Employees: 71
Company Website: https://icecure-medical.com/
Investor Relations: http://ir.icecure-medical.com
Phone: 97246230333
ICECURE MEDICAL LTD / ICCM FAQ
What is the stock price of ICECURE MEDICAL LTD today?
The current stock price of ICCM is 1.41 USD. The price decreased by -6% in the last trading session.
What is the ticker symbol for ICECURE MEDICAL LTD stock?
The exchange symbol of ICECURE MEDICAL LTD is ICCM and it is listed on the Nasdaq exchange.
On which exchange is ICCM stock listed?
ICCM stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for ICECURE MEDICAL LTD stock?
9 analysts have analysed ICCM and the average price target is 3.2 USD. This implies a price increase of 127.15% is expected in the next year compared to the current price of 1.41. Check the ICECURE MEDICAL LTD stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is ICECURE MEDICAL LTD worth?
ICECURE MEDICAL LTD (ICCM) has a market capitalization of 79.76M USD. This makes ICCM a Micro Cap stock.
How many employees does ICECURE MEDICAL LTD have?
ICECURE MEDICAL LTD (ICCM) currently has 71 employees.
What are the support and resistance levels for ICECURE MEDICAL LTD (ICCM) stock?
ICECURE MEDICAL LTD (ICCM) has a support level at 1.3. Check the full technical report for a detailed analysis of ICCM support and resistance levels.
Is ICECURE MEDICAL LTD (ICCM) expected to grow?
The Revenue of ICECURE MEDICAL LTD (ICCM) is expected to grow by 11.03% in the next year. Check the estimates tab for more information on the ICCM EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy ICECURE MEDICAL LTD (ICCM) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of ICCM, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of ICCM, evaluating the profitability, health, valuation and growth aspects
- ICECURE MEDICAL LTD (ICCM) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- ICECURE MEDICAL LTD (ICCM) Sales and EPS estimates to see what analysts future expectations are.
- ICECURE MEDICAL LTD (ICCM) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- ICECURE MEDICAL LTD (ICCM) Insider and Institutional Ownership to learn about the owners and their transactions.
- ICECURE MEDICAL LTD (ICCM) Stock Chart to make your own analysis
- ICECURE MEDICAL LTD (ICCM) Latest news and press-releases to stay up to date.
Does ICECURE MEDICAL LTD (ICCM) stock pay dividends?
ICCM does not pay a dividend.
What is the Price/Earnings (PE) ratio of ICECURE MEDICAL LTD (ICCM)?
ICECURE MEDICAL LTD (ICCM) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.29).
What is the Short Interest ratio of ICECURE MEDICAL LTD (ICCM) stock?
The outstanding short interest for ICECURE MEDICAL LTD (ICCM) is 2.76% of its float. Check the ownership tab for more information on the ICCM short interest.
ICCM Technical Analysis
ChartMill assigns a technical rating of 9 / 10 to ICCM. When comparing the yearly performance of all stocks, ICCM is one of the better performing stocks in the market, outperforming 94.64% of all stocks.
ICCM Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to ICCM. The financial health of ICCM is average, but there are quite some concerns on its profitability.
ICCM Financial Highlights
Over the last trailing twelve months ICCM reported a non-GAAP Earnings per Share(EPS) of -0.29. The EPS increased by 20.17% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -90.55% | ||
| ROE | -137.51% | ||
| Debt/Equity | 0 |
ICCM Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 82% to ICCM. The Buy consensus is the average rating of analysts ratings from 9 analysts.
For the next year, analysts expect an EPS growth of 3.56% and a revenue growth 11.03% for ICCM